10月 2025
- 首頁
- New England Biolabs, Inc.
10月 2025New England Biolabs, Inc.的市場佔有率分析
neb is a leader in the discovery and development of molecular biology reagents. restriction enzymes, polymerases, competent cells,sample prep for ngs, and more.
New England Biolabs, Inc.(包含公司地區)
查看更多網站流量與參與度資訊- neb.com
New England Biolabs, Inc.截至 10月 2025 的總收入為 100M - 200M
New England Biolabs, Inc. 熱門網域產生的總收入
New England Biolabs, Inc. 熱門網域 3 年內的總收入
New England Biolabs, Inc. 熱門網域的總收入
New England Biolabs, Inc.的熱門網域總造訪量
了解New England Biolabs, Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
New England Biolabs, Inc.的熱門網域平均造訪時長
分析New England Biolabs, Inc.參與度指標。
過去 3 個月平均造訪時長
子公司細目
New England Biolabs, Inc.的熱門網域平均頁面瀏覽量
了解New England Biolabs, Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自New England Biolabs, Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞New England Biolabs, Inc. launched NEBNext Flu A Integrated Indexing Primer Module on Nov 14th '25.New England Biolabs (NEB(R) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), designed to streamline and scale the sequencing of Influenza A virus from a range of species and sample types using Oxford Nanopore Technologies (ONT) platforms.
11月 14, 2025閱讀更多
新聞New England Biolabs, Inc. attended event Association for Molecular Pathology (AMP) Annual Meeting & Expo on Nov 11th '25.IPSWICH, Mass., Nov. 10, 2025 /PRNewswire/ - New England Biolabs (NEB(R), a global leader in enzyme technologies and molecular biology solutions, will highlight its latest advances in molecular diagnostics and infectious disease surveillance at the Association for Molecular Pathology (AMP) Annual Meeting & Expo, taking place November 11 - 15, 2025, in Boston, MA.
11月 10, 2025閱讀更多
新聞Hunts Office partners with New England Biolabs, Inc..Hunts Office partnered with NEB to create a workspace that reflects the company's commitment to innovation and sustainability.
9月 16, 2025閱讀更多
查看所有New England Biolabs, Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。